Part I : The Business Culture of Science
Since 2000, there has been a 20-fold increase* in research funding for anti-aging medicine. Wow! That’s a good thing. But let’s keep our eyes on the ball. There is danger that this welcome infusion of capital may be biasing research priorities toward those that are most likely to be profitable, and maybe even diverting the best researchers from the radical thinking that will change our understanding of biology.
Whoever discovers an effective age-reversal treatment is destined to become a multi-billionaire!
At first blush, this statement seems obvious, but that doesn’t mean it’s true. There are
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.